Scientists Probe Obesity's Ties to Breast Cancer Risk

Findings suggest heavy women might need more focused screening

Wednesday, August 19, 2015

WEDNESDAY, Aug. 19, 2015 (HealthDay News) -- Obesity is a well-known risk factor for breast cancer, but researchers haven't figured out what connects the two. A new study suggests the link may be due to a change in breast tissue structure, which might promote breast cells to progress to cancer.

The findings, based on research with tissue from mice and humans, emphasize the need to encourage a healthy weight in women who have breast cancer and in general. The results may also have implications for breast cancer detection and breast reconstruction surgeries, the researchers reported in the Aug. 19 issue of Science Translational Medicine.

The authors of an editorial accompanying the paper said the findings could be key to solving the puzzle of how obesity leads to breast cancer or worsens outcomes for women with the disease. This kind of information could open the way to treatments that target those pathways, according to Lisa Arendt, a research assistant professor, and Charlotte Kuperwasser, an associate professor, at Tufts University in Boston.

"Unfortunately, therapeutics specific for obese women with breast cancer are limited," Arendt and Kuperwasser wrote. They said that obesity accounts for as much as one-fifth of all cancer deaths among women.

The processes underlying the obesity-breast cancer link had left specialists stumped, although some had proposed obesity-related differences in hormones or inflammation. But obesity-related stiffening of breast tissues was not high on the list.

In the new work, Cornell University doctoral student Bo Ri Seo and colleagues looked at breast fat tissue in humans and mice. They found that in obesity, the web-like network of fibers holding fat cells in place is more rigid than normal.

Curious about whether obesity-related genetics might play a role, the researchers compared tissues of mice that were genetically obese and mice that became obese from overfeeding. Regardless of how they became obese, their tissues still were stiffened, the investigators found.

The researchers also ruled out a common inflammation-related molecule as playing a role. They concluded that the stiff structure itself seemed to be the relevant factor.

To assess that idea further, the study authors also exposed precancerous breast cells to these stiff fibrous networks from obesity-related tissue samples. Cells growing under these conditions were more likely to become completely cancerous compared to those grown in non-obesity-related samples.

Finally, the researchers turned to the obvious question: Would weight loss reduce this stiffening effect?

When the researchers placed obese mice on a diet, the fibrous network thinned out a little, "hinting that weight loss can potentially reverse this tissue stiffening," the study authors explained in a journal news release.

Another question is how obesity leads to the stiffer tissues. Arendt and Kuperwasser said that low oxygen in the denser tissues might be one explanation. And, they noted, it's still possible that an inflammatory process plays a role.

Dense breast tissue on a mammogram is associated with a higher probability of developing breast cancer, Seo and her co-authors pointed out. But fat tissue might mask this kind of density, they added, suggesting that for obese women, more focused, high-resolution imaging might be called for to detect hidden areas of density.

The study authors also noted that using donor breast tissue to regenerate breasts after complete breast removal is becoming a possibility. If donor tissue from obese women might carry a risk of promoting cancerous changes in breast cells, that factor may need to be considered, they suggested.

Obesity-related breast cancer rates are likely to increase as obesity rates keep rising, Arendt and Kuperwasser warned. Currently, weight loss is the only recommendation for obesity in women diagnosed with breast cancer.

Diabetic women who take the drug metformin have a lower risk of developing breast cancer. For this reason, this diabetes drug is also being tested in clinical trials as treatment for obesity-associated breast cancer, the editorialists said.

But little research has addressed how weight loss might affect risk for developing breast cancer in the first place. One recent study, Arendt and Kuperwasser wrote, found no effect of short-term weight loss on this risk in postmenopausal women.

SOURCE: Aug. 19, 2015, Science Translational Medicine, online

HealthDay